highly significantP < 0.001
Sensorineural hearing loss was detected in 65.1% of male patients, while hearing survival periods showed a highly significant difference between the non-truncating and truncating groups ( P < 0.001, HR 5.1).
Sensorineural hearing loss was detected in 65.1% of male patients, while hearing survival periods showed a highly significant difference between the non-truncating and truncating groups ( P < 0.001, HR 5.1).
The development of hearing loss and ocular changes showed a trend similar to that of kidney prognosis 4 , 5 , 7 .